**Question:** Propranolol is contraindicated in diabetes mellitus because it

A. lowers blood glucose levels
B. increases insulin secretion
C. decreases heart rate
D. improves glycemic control

**Correct Answer:** A. lowers blood glucose levels

**Core Concept:** Propranolol is a beta-blocker, a class of medications that block the action of adrenaline (epinephrine) and norepinephrine on beta receptors. In diabetes mellitus, hyperglycemia is a primary feature caused by inadequate insulin secretion and/or insulin resistance.

**Why the Correct Answer is Right:** Propranolol lowers blood glucose levels by blocking the beta-1 receptors in the heart, which reduces the heart rate and myocardial oxygen demand, leading to improved cardiac output and decreased glucose utilization by the heart. This reduction in glucose utilization contributes to the overall decrease in blood glucose levels. In diabetes mellitus, the primary goal of therapy is to maintain blood glucose levels within normal limits, so using a beta-blocker like propranolol can exacerbate the hyperglycemic state.

**Why Each Wrong Option is Incorrect:**

**Option B (Incorrect)**: Insulin secretion is not directly influenced by beta-blockers like propranolol. While diabetes mellitus is characterized by inadequate insulin secretion, propranolol's mechanism of action does not address this aspect of the disease.

**Option C (Incorrect)**: Propranolol does not primarily affect heart rate as a beta-blocker. While it does decrease heart rate, the primary concern in diabetes mellitus is blood glucose control, not heart rate.

**Option D (Incorrect)**: Propranolol does not improve glycemic control in diabetes mellitus. As mentioned earlier, the primary goal of therapy in diabetes mellitus is to maintain blood glucose levels within normal limits, and using a beta-blocker like propranolol exacerbates the hyperglycemic state.

**Clinical Pearl:** In the context of diabetes mellitus, beta-blockers like propranolol should be avoided as they can worsen glycemic control. Instead, pharmacological agents that improve insulin secretion or sensitivity should be considered for blood glucose management in diabetes.